Demin Li
PhD, MBBS, MSc
Visiting Scientist
- Senior Research Fellow
Understanding immune recognition and developing cancer immunotherapy.
Recent publications
-
Immunopeptidomic Profiling of HLA-A2-Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens.
Journal article
Ternette N. et al, (2018), Proteomics, 18
-
Development of a T-cell Receptor Mimic Antibody against Wild-Type p53 for Cancer Immunotherapy.
Journal article
Li D. et al, (2017), Cancer Res, 77, 2699 - 2711
-
Engineering chimeric human and mouse major histocompatibility complex (MHC) class I tetramers for the production of T-cell receptor (TCR) mimic antibodies.
Journal article
Li D. et al, (2017), PLoS One, 12
-
Therapeutic Antibodies against Intracellular Tumor Antigens.
Journal article
Trenevska I. et al, (2017), Front Immunol, 8
-
The European antibody network's practical guide to finding and validating suitable antibodies for research.
Journal article
Roncador G. et al, (2016), MAbs, 8, 27 - 36
ORCID
0000-0002-7118-3401